Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

CU-CPT17e is an agonist of toll-like receptor 3 (TLR3), TLR8, and TLR9.1 It selectively induces NF-κB activation in HEK293 cells expressing recombinant human TLR3, TLR8, or TLR9 (EC50s = 4.8, 13.45, and 5.66 µM, respectively) over HEK293 cells expressing recombinant human TLR2, TLR4, TLR5, or TLR7 (EC50s = >100 µM for all). CU-CPT17e (5-40 µM) induces TNF-α, IL-6, and IL-8 production in THP-1 cells. It also inhibits the growth of HeLa cells (IC50 = 2.71 µM).
WARNING This product is not for human or veterinary use.
1. Discovery of small molecules as multi-